2 天前 - … PURPOSE: Diagnosis of interstitial lung disease (ILD) poses a significant challenge
for clinicians and often delayed by several years. The factors underpinning these delays …

2 天前 - PURPOSE: While previous research has elucidated the detrimental effects of
tobacco smoking in patients with interstitial lung disease (ILD), there remains a notable gap in …

2 天前 - … perceived communication around antifibrotic treatment options. A greater proportion
of people at ILD centers reported participating in pulmonary rehabilitation and exercise to …

2 天前 - … PURPOSE: The pathogenesis of scleroderma associated interstitial lung disease
(SSc-ILD) involves the uncontrolled differentiation of normal human lung fibroblasts (NHLFs) …

2 天前 - … as a potential inhaled treatment option for PH diseases characterized by
underlying pulmonary vascular and interstitial fibrosis, such as WHO Group 1 and Group 3 PH. …

2 天前 - … The index date was the date of initiation of maintenance inhaled treatment.
Patients with asthma, interstitial lung disease, cystic fibrosis, or lung cancer during the 12-month …

2 天前 - … worsen chronic medical conditions. Individuals with pre-existing chronic lung
diseases … , Mainz, Germany), among adults in the United States (US) with chronic lung disease. …

2 天前 - … PURPOSE: The observation of interstitial lung abnormalities (ILA) on chest CT
suggests the presence of interstitial lung disease (ILD) in individuals without ILD or ILD risk …

2 天前 - … PURPOSE: The diagnosis of fibrotic interstitial lung disease (ILD) is often delayed
due to challenges in differentiating “common” symptoms (eg, cough, dyspnea, reduced …

2 天前 - … with respiratory symptoms, including dyspnea, cough, and fever. The worsening
pulmonary condition, … raised concerns of interstitial lung disease or opportunistic infection. This …